Middletown, DE -- (SBWIRE) -- 09/19/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Warner Chilcott Plc(NASDAQ:WCRX), Onyx Pharmaceuticals, Inc.(NASDAQ:ONXX), Amgen, Inc.(NASDAQ:AMGN), Akamai Technologies, Inc.(NASDAQ:AKAM)
Warner Chilcott Plc (NASDAQ:WCRX) gained volume of 2.62 million shares and the average volume of the stock remained 2.50 million shares. The 52 week range of the stock remained $10.85 - $22.45 and the day range was $21.77 - $22.17.The stock opened the session at $21.96, and closed the session at $22.15. The stock showed a positive performance of +1.10% in previous trading session. Warner Chilcott Public Limited Company, a specialty pharmaceutical company, engages in the development, manufacture, promotion, and franchise of branded pharmaceutical products focusing on the women?s healthcare, gastroenterology, urology, and dermatology markets.
For How Long WCRX’s Gloss will Attract Investors? Find out via this report
In previous session, Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) traded 2.65 million shares and the average volume of the stock remained 3.53 million shares. The 52 week range of the stock remained $68.12 - $136.87. The stock was a bear and dropped -0.18%, while its closing price stayed at $123.30. The market capitalization of the stock remained 9.04 billion. The half-yearly trend of the stock remained positive +42.36%. Onyx Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies that target the molecular mechanisms that cause cancer in the United States and internationally.
Has ONXX Found The Bottom And Ready To Gain Momentum? Find Out Here
Amgen, Inc.(NASDAQ:AMGN) volume of the stock was 2.61 million shares in the most recent session and the average volume remained 3.45 million shares. The stock boosted +1.55% and finished the prior session at the closing price of $117.52. The stock traded 2.61 million shares in its previous trading session and its average volume remained 3.45 million shares. Amgen Inc., a biotechnology medicines company, engages in the discovery, development, manufacture, and marketing of human therapeutic products in the areas of supportive cancer care, inflammation, nephrology, and bone diseases primarily in the United States, Europe, and Canada.
Will AMGN Continue To Move Higher? Find Out Here
Akamai Technologies, Inc. (NASDAQ:AKAM) traded with volume of 2.54 million shares and the average volume of the stock remained 1.38 million shares. The stock grew +1.55% and finished the trading at $52.38. The market capitalization of the stock remained 9.33 billion. The beta of the stock remained 0.77. Akamai Technologies, Inc. provides content delivery and cloud infrastructure services for accelerating and improving the delivery of content and applications over the Internet in the United States and internationally. It offers application and cloud performance services, solutions for digital media and software distribution and storage.
Why Should Investors Buy AKAM After The Recent Gain? Just Go Here and Find Out
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)